According to OptiNose's latest financial reports the company's current EPS (TTM) is -$0.50. In 2022 the company made an earnings per share (EPS) of -$0.89 an increase over its 2021 EPS that were of -$1.48.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.50 | -43.82% |
2022 | -$0.89 | -39.86% |
2021 | -$1.48 | -28.85% |
2020 | -$2.08 | -20.91% |
2019 | -$2.63 | -2.59% |
2018 | -$2.70 | 40.23% |
2017 | -$1.93 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -46.00% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | 100.00% | ๐บ๐ธ USA |